| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |